Clincosm LogoSign in Get a demo

Deltalus: Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure

Sponsor
University of Monastir (Other)
Overall Status
Recruiting
CT.gov ID
NCT05871138
Collaborator
(none)
500
Enrollment
2
Locations
9
Anticipated Duration (Months)
250
Patients Per Site
27.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge.

    Delta LUS score=((LUS2-LUS1) *100)/LUS1

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure Within 30 Days of Discharge
    Actual Study Start Date :
    Mar 30, 2023
    Anticipated Primary Completion Date :
    Dec 30, 2023
    Anticipated Study Completion Date :
    Dec 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Delta lus [30 days]

      The primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac

    2. Readmission [30 days]

      Readmission

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients aged over 18 years,

    • Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).

    Exclusion Criteria:

    • Age less than 18 years

    • Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)

    • Altered state of consciousness (Glasgow score<14)

    • Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs

    • Mechanical ventilation from the outset

    • Cardiorespiratory arrest

    • Inability to give consent to the study

    • Missing one of two ultrasound examinations

    • Unable to make telephone contact after one month.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Semir Nouira Monastir Monastur Tunisia 5000
    2 Emergency Departement Monastir Tunisia 5000

    Sponsors and Collaborators

    • University of Monastir

    Investigators

    • Principal Investigator: Nouira Semir, Pr, University of Monastir

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pr. Semir Nouira, clinical proffesor, University of Monastir
    ClinicalTrials.gov Identifier:
    NCT05871138
    Other Study ID Numbers:
    • Delta- LUS
    First Posted:
    May 23, 2023
    Last Update Posted:
    May 23, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pr. Semir Nouira, clinical proffesor, University of Monastir
    Delta-lus score
    heart failure
    Additional relevant MeSH terms:
    Heart Failure
    Emergencies

    Study Results

    No Results Posted as of May 23, 2023